Ambu ASAMBBY 84 Pretax Margin % is 9.98% as of Mar. 2026, which is 7% below its 10-year median of 10.77. GuruFocus rates AMBBY with a GF Score™ of 84/100 and a GF Value™ of $19.84 (Significantly Undervalued). Among 817 Medical Devices & Instruments companies, Ambu AS ranks better than 68.3% on this metric.
Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Ambu AS's Pre-Tax Income for the
three
months ended in Mar. 2026 was $24.3 Mil. Ambu AS's Revenue for the
three
months ended in Mar. 2026 was $243.3 Mil. Therefore, Ambu AS's pretax margin for the quarter that ended in Mar. 2026 was 9.98%.
The historical rank and industry rank for Ambu AS's Pretax Margin % or its related term are showing as below:
AMBBY'
s Pretax Margin % Range Over the Past 10 Years
Min: 2.45 Med: 10.77 Max: 17.84
Current: 10.16
AMBBY's Pretax Margin % is ranked better than 68.3% of 817
companies
in the Medical Devices & Instruments industry
Industry Median: 2.61
vs AMBBY: 10.16
Ambu AS (OTCPK:AMBBY) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Ambu AS Pretax Margin % Related Terms
Ambu AS Pretax Margin % Historical Data
* Premium members only.
The historical data trend for Ambu AS's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AMBBY vs ABT, SYK, MDT: Pretax Margin % Comparison
For the Medical Devices subindustry, Ambu AS's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ambu AS Pretax Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Ambu AS's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Ambu AS's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ambu AS (AMBBY) has a Pretax Margin % of 9.98% as of Mar. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Ambu AS and its competitors. This is near median its historical median of 10.77. Over the past decade, Ambu AS's Pretax Margin % has ranged from 2.45 to 17.84. According to the industry distribution chart, Ambu AS ranks #259 out of 817 companies in the Medical Devices & Instruments industry, placing it in the top 31.7%.
Is Ambu AS's Pretax Margin % too high?
Ambu AS's current Pretax Margin % of 9.98% is near median its 10-year median of 10.77. Over the past 10 years, this metric has ranged from a low of 2.45 to a high of 17.84. The Medical Devices & Instruments industry median Pretax Margin % is 2.61. Ambu AS's value of 9.98% is 282.4% above this industry median. Based on the distribution chart, Ambu AS ranks #259 out of 817 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Ambu AS has a GF Score™ of 84/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Ambu AS's Pretax Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Ambu AS ranks #259 out of 817 companies for Pretax Margin %. This puts Ambu AS in the upper half of its industry. The industry median Pretax Margin % is 2.61. Ambu AS's value of 9.98% is 282.4% above this benchmark. Historically, Ambu AS's own Pretax Margin % has ranged from 2.45 to 17.84 over the past decade. While the company's 10-year median is 10.77 vs. the industry median of 2.61, Ambu AS has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Medical Devices & Instruments company?
The median Pretax Margin % among Medical Devices & Instruments companies is 2.61, based on 817 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ambu AS's current Pretax Margin % of 9.98% is 282.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Ambu AS and its competitors. For the Medical Devices & Instruments industry, the median Pretax Margin % is 2.61 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ambu AS's current Pretax Margin % is 9.98%, which is near median its own 10-year median of 10.77. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ambu AS stock overvalued right now?
Based on GuruFocus' analysis, Ambu AS (AMBBY) is currently considered Significantly Undervalued. The stock's GF Value™ is $19.84, compared to a current price of $9.43 — trading 52.5% below its estimated fair value. The current Pretax Margin % is 9.98%, which is near median its 10-year median of 10.77 and 282.4% above the Medical Devices & Instruments industry median of 2.61. Ambu AS's overall GF Score™ is 84/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Ambu AS (AMBBY), the current Pretax Margin % is 9.98% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ambu AS (AMBBY) Overvalued in 2026?
Based on GuruFocus' analysis, Ambu AS stock appears to be undervalued.
The current stock price of $9.43 is trading 52.5% below its estimated GF Value™ of $19.84.
GuruFocus considers Ambu AS to be Significantly Undervalued.
Key valuation signals for AMBBY:
Pretax Margin %: 9.98% (near median its 10-year median of 10.77)
GF Value™: $19.84 vs. price of $9.43 (52.5% below fair value)
Industry Position: 282.4% above the Medical Devices & Instruments median (#259 of 817)
No single metric tells the full story. See the AMBBY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ambu AS provides medical technology solutions. The company's business consists of research and development of new solutions, which are then manufactured, marketed, and sold. It operates in two verticals: Endoscopy Solutions and Anesthesia & Patient Monitoring, with the majority of revenue being generated from the Endoscopy Solutions business. Geographical segments include North America, Europe, and the Rest of the World.
84GF Score
Get the complete analysis for AMBBY
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AMBBY has been successfully added to your 
